Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites
Thursday, July 25, 2013
Cerilliant also offers the corresponding deuterium-labeled internal standard.

Hurel Corporation Launches Cell-Based In Vitro Testing Product Suite
Wednesday, July 17, 2013
Suite is milestone in movement away from use of live animals in drug and toxicity testing.

Phenom-World Unveils the Third Generation Phenom Desktop SEM
Tuesday, June 25, 2013
With a magnification range up to 100,000x and resolution of 17nm the Phenom ProX delivers more detailed information than ever before.

Agilent Introduces Advanced Mass Spec Software
Tuesday, June 11, 2013
New applications to optimize food and forensics analyses and biopharmaceutical characterization.

Agilent Launches RapidFire 365 High-Throughput Mass Spectrometry System
Tuesday, June 11, 2013
Product provides walkaway mass spectrometric analysis for researchers working on drug discovery, clinical research and forensic toxicology.

Optibrium Introduces StarDrop 5.4 to Target Novel, Safe and Efficacious Drugs
Tuesday, June 11, 2013
Next generation software adds modules for knowledge-based prediction of toxicity and application of over 20,000 bioisosteric transformations.

Bruker Unveils Mass Spectrometry-Based Products at ASMS
Monday, June 10, 2013
Bruker announces powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets.

Molecular Devices to Exhibit at French Neuroscience 2013
Monday, May 13, 2013
Molecular Devices will be showcasing their Axon™ Digidata® 1550 Low-Noise Data Acquisition System.

Molecular Devices Launches Axon Digidata 1550 Low-Noise Data Acquisition System
Thursday, May 09, 2013
High performance, high throughput system designed to support the most challenging electrophysiology research.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 62
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv